# A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant

> **NCT06867952** · NA · RECRUITING · sponsor: **S.LAB (SOLOWAYS)** · enrollment: 40 (estimated)

## Conditions studied

- Osteoporosis
- Osteopenia

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin K2 plus vitamin D3
- **DIETARY_SUPPLEMENT:** Vitamin K2 plus vitamin D3

## Key facts

- **NCT ID:** NCT06867952
- **Lead sponsor:** S.LAB (SOLOWAYS)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-03
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-03-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06867952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06867952, "A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06867952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*